Alanna K. Rahm, PhD, MS

Articles by Alanna K. Rahm, PhD, MS

Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study

ByKatrina A.B. Goddard, PhD,Erin J. Aiello Bowles, MPH,Heather Spencer Feigelson, PhD, MPH,Laurel A. Habel, PhD,Sharon Hensley Alford, PhD,Catherine A. McCarty, PhD, MPH,Larissa Nekhlyudov, MD, MPH,Adedayo A. Onitilo, MD, MSCR, FACP,Alanna K. Rahm, PhD, MS,Jennifer A. Webster, MS

November 20th 2012

Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.

Latest Updated Articles

Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study
Published: November 20th 2012 | Updated:

Alanna K. Rahm, PhD, MS

Articles by Alanna K. Rahm, PhD, MS

Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study

Latest Updated Articles

Trending on AJMC

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause

IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?

Revumenib Granted FDA Approval for R/R NPM1-Mutated AML

FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma

Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates